Examkin

Question

Difficulty: HardDisposition and Care Setting Transitions

A 75-year-old man is hospitalized for his fourth exacerbation of heart failure in the past 6 months. He has New York Heart Association (NYHA) Class IV heart failure with a left ventricular ejection fraction of 15%. His home medications include maximum tolerated doses of carvedilol, sacubitril-valsartan, spironolactone, and dapagliflozin. During this admission, he required a continuous milrinone infusion to relieve severe dyspnea at rest and maintain adequate end-organ perfusion. Over the past 48 hours, attempts to wean the milrinone have repeatedly resulted in worsening respiratory distress and an acute rise in his serum creatinine from 1.4 mg/dL to 2.9 mg/dL. He has been evaluated by the advanced heart failure team and is not a candidate for a ventricular assist device or cardiac transplantation due to age and multiple comorbidities.

During a family meeting, the patient states, "I am tired of being in the hospital. I just want to go home and be comfortable. I do not want any more aggressive treatments or to be readmitted." He lives in a single-story home with his daughter, who is willing and able to provide 24-hour care.

Which of the following is the most appropriate disposition for this patient?

  1. Discharge home with hospice servicesAnswer
  2. B
    Discharge home with home health agency services
  3. C
    Transfer to an inpatient hospice facility
  4. D
    Transfer to a long-term acute care hospital
  5. E
    Transfer to a skilled nursing facility

Answer

Discharge home with hospice services
The correct answer represents the only disposition that simultaneously manages the patient's complex medical needs while honoring his explicit goals of care. This patient has end-stage (Stage D) heart failure, is inotrope-dependent, and is ineligible for advanced cardiac therapies. His estimated life expectancy is less than 6 months, qualifying him for hospice care. His explicit goals are to prioritize comfort, avoid further aggressive treatments, and return home. Home hospice services are uniquely designed to provide comprehensive, multidisciplinary end-of-life care in the home setting. Crucially, continuous intravenous inotropes (such as milrinone or dobutamine) can be safely continued at home under hospice care when their purpose has shifted from a 'bridge to therapy' to symptom palliation (e.g., relieving resting dyspnea). Because he has a capable, full-time caregiver (his daughter) and his symptoms are currently stable on his infusion dose, he can safely be transitioned to the home environment.

Step-by-Step Solution

1
Identify the patient's clinical status and prognosis.
The patient has Stage D, NYHA Class IV heart failure, is dependent on continuous IV milrinone, and is ineligible for advanced therapies (VAD/transplant), indicating a life expectancy of less than 6 months.
Establishing prognosis is required to determine eligibility for the Medicare Hospice Benefit.
2
Clarify the patient's goals of care.
The patient explicitly requests comfort-focused care ('be comfortable', 'no more aggressive treatments') and wishes to return to his home environment.
Patient autonomy and goals of care directly dictate the most appropriate transition pathway.
3
Evaluate the clinical feasibility of care setting options.
The patient requires ongoing continuous IV inotropic therapy for symptom palliation (relieving dyspnea and end-organ dysfunction) rather than as a restorative bridge.
Care settings must possess the clinical capabilities and administrative structure to manage the patient's specific medical requirements.
4
Match the clinical needs and patient goals to the correct disposition.
Home hospice is selected.
Home hospice uniquely aligns with his goals by providing comprehensive end-of-life comfort care at home. Crucially, home hospice agencies can safely manage continuous palliative IV inotropes for symptom control.

Key Concept

Continuous intravenous inotropes can be continued at home under hospice care when utilized strictly for symptom palliation in patients with end-stage heart failure whose goals of care emphasize comfort over life prolongation.
Rate this question

Topics

Disposition and Care Setting Transitions

More questions from this topic